✦ LIBER ✦

Cyclooxygenase-2 inhibitors in patients with high gastrointestinal risk: are we there yet?

✍ Scribed by Vincent Wai-Sun Wong; Francis Ka-Leung Chan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

COX-2-selective inhibitors and the risk

✍ B. Nørgård; L. Pedersen; S. P. Johnsen; R. E. Tarone; J. K. McLaughlin; S. Friis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Long-term low-dose maintenance pegylated

✍ Gennaro D'Amico; Fabio Tine 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

The spectrum of gastrointestinal toxicit

✍ Robin Matuk; Jonathan Crawford; Maria T. Abreu; Stephan R. Targan; Eric A. Vasil 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Type 2 diabetes mellitus and obesity are

✍ Lola B. Chambless; Scott L. Parker; Laila Hassam-Malani; Matthew J. McGirt; Reid 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 216 KB

MAGNA CARTAThe Great CharterPreamble

📂 Fiction 🌐 English ⚖ 11 KB 👁 18 views